CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in BEAM — Beam Therapeutics Inc.
CIK 884546
SAN FRANCISCO, CA
Position in BEAM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$30,404,156
+$11,139,127 QoQ
Shares Held
885,902
+9.6% QoQ
Ownership
0.858%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 274 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. BEAM ranks #49 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in BEAM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,404,156 | 885,902 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,265,029 | 808,436 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $23,140,517 | 834,795 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,416,166 | 841,210 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $13,180,215 | 774,851 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $15,163,970 | 776,445 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $16,093,836 | 648,945 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $15,422,554 | 629,492 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,900,222 | 593,266 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $19,139,146 | 579,272 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $15,549,043 | 571,236 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $13,020,910 | 541,410 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $16,010,340 | 501,420 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $14,195,860 | 463,614 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $18,035,732 | 461,154 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $21,528,849 | 451,907 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,385,250 | 397,449 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $21,253,486 | 370,916 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $27,718,094 | 347,824 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $29,019,575 | 333,520 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $32,363,099 | 251,442 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $17,584,147 | 219,692 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $16,628,598 | 203,682 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,222,600 | 171,511 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,312,856 | 82,602 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $468,090 | 26,005 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||